Prof Marina Pajic will break down tumours’ protective barriers using integrin inhibitors to help chemotherapy work better. Dr Orion Tong will develop blood tests that detect multiple DNA signatures to catch pancreatic cancer early. Read more: ow.ly/iA0b50Xuutu
#PancreaticCancer

Read the full study: pubmed.ncbi.nlm.nih.gov/40977519/
#CancerResearch #BRCA #PrecisionMedicine

When lab results align with patient outcomes, drug development becomes more efficient and promising treatments reach patients faster.

Why does this matter? It helps researchers worldwide choose more reliable testing methods when developing new therapies.

We found that genetically matched cells (where scientists control specific gene changes) accurately predict patient responses, while standard cancer cell collections often show different patterns.

But what is the AllClear program about, and what will it achieve?

To read more about this research, click here: ow.ly/MA8q50WZ834

This is the first time researchers have dissected tumour cell diversity with such precision and could transform how cancer is treated.

ow.ly/2pz650WgvKP

AAnet, led by A/Prof Christine Chaffer, Prof Sarah Kummerfeld & A/Prof Smita Krishnaswamy, maps tumour cells into 5 distinct groups, each with vastly different biology.

Tumours aren’t just one type of cell — they’re a mix, each responding to treatment differently. But today, most cancer therapies treat them all the same.